Exelixis (NASDAQ: EXEL) announced that it has extended and restructured its agreement with Swedish Orphan Biovitrum AB (Sobi) to support ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE